HIV Prevention Program for Patients Receiving Care at a Sexually Transmitted Diseases Clinic
HIV Prevention for STD Clinic Patients
1 other identifier
interventional
1,554
1 country
1
Brief Summary
This study will determine the effectiveness of a two-step HIV prevention program in reducing risky sexual practices and decreasing the incidence of sexually transmitted diseases (STDs).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2 hiv-infections
Started Mar 2004
Typical duration for phase_2 hiv-infections
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2004
CompletedFirst Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 16, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2007
CompletedJune 7, 2013
June 1, 2013
3.3 years
September 13, 2005
June 6, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sexual behavior
12 months
Secondary Outcomes (1)
STD incidence
12 months
Study Arms (6)
1
EXPERIMENTALBrief Motivational Intervention only
2
EXPERIMENTALBrief Informational Intervention only
3
EXPERIMENTALBrief Motivational Intervention + Intensive Informational Intervention
4
EXPERIMENTALBrief Motivational Intervention + Intensive Information-Motivation-Behavioral Skills Intervention
5
EXPERIMENTALBrief Informational Intervention + Intensive Informational Intervention
6
EXPERIMENTALBrief Informational Intervention + Intensive Information-Motivation-Behavioral Skills Intervention
Interventions
4-hour, intensive group workshop with emphasis on motivation and skills
Eligibility Criteria
You may qualify if:
- Diagnosis or symptoms of an STD within 3 months prior to study entry OR have had unprotected vaginal or anal intercourse with one or more of the following: two or more sexual partners, a partner with two or more partners, an anonymous partner, an injection drug-using partner, or a partner with an STD
- Able to understand English
You may not qualify if:
- Psychosis or impaired mental status that would prevent participant from providing informed consent
- Have been tested for HIV within 3 months prior to study entry
- HIV infected
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Miriam Hospitallead
- National Institute of Mental Health (NIMH)collaborator
- University of Rochestercollaborator
- Syracuse Universitycollaborator
Study Sites (1)
Syracuse University
Syracuse, New York, 13244, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael P. Carey, PhD
Syracuse University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, CBPM
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 16, 2005
Study Start
March 1, 2004
Primary Completion
July 1, 2007
Study Completion
July 1, 2007
Last Updated
June 7, 2013
Record last verified: 2013-06